Ramdan Hours:
Sun - Thu
9.30 AM - 2.30 PM
Iftar in --:--:--
🌙 Maghrib: --:--

Clinicians' guide to Aspirin / (Record no. 2145)

MARC details
000 -LEADER
fixed length control field 02025nam a22002417i 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20200929111607.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 100913s1998 enk||||| |||| 00| 0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 0412819007 (pbk.)
040 ## - CATALOGING SOURCE
Original cataloging agency EG-NcFUE
Description conventions rda
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Edition number 21
Classification number 615.3137
Item number B.A.C
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Bayer, Antony.
9 (RLIN) 8803
Relator term author.
245 10 - TITLE STATEMENT
Title Clinicians' guide to Aspirin /
Statement of responsibility, etc Antony Bayer.
264 #1 - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication, distribution, etc London :
Name of publisher, distributor, etc Chapman and Hall Medical,
Date of publication, distribution, etc 1998.
300 ## - PHYSICAL DESCRIPTION
Extent vii, 174 pages, [8] pages of plates :
Other physical details illustrations (chiefly color), portrait ;
Dimensions 25 cm
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term unmediated
Media type code n
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term volume
Carrier type code nc
Source rdacarrier
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references and index.
505 ## - FORMATTED CONTENTS NOTE
Formatted contents note Historical background -- Early history -- Reverend Mr. Edward Stone -- 19th century -- Felix Hoffmann and the Bayer Company -- Antithrombotic effects and prevention of vascular events -- Mechanism of action -- Pharmacokinetics and pharmaceutical considerations -- Physicochemical properties -- Pharmacokinetics -- Which preparation? -- Mode of action and pharmacological effects -- Mode of action -- Therapeutic use for inflammation, pain and fever -- Inflammation -- Pain -- Fever -- Therapeutic use in vascular diseases -- Primary prevention of occlusive cardiovascular disease -- Secondary prevention of occlusive cardiovascular disease -- Maintenance of vascular grafts and arterial patency -- What dose? -- Miscellaneous therapeutic uses -- Prevention of colorectal cancer -- Prevention of other cancers -- Prevention of cataract -- Pregnancy -- Prevention of cognitive decline and dementia -- Other possible therapeutic uses -- Adverse effects and toxicity -- Gastrointestinal side effects -- Intracranial bleeding -- Hypersensitivity -- Reye's syndrome -- Other adverse effects -- Toxicity -- Contraindications and drug interactions -- Contraindications and precautions -- Use in particular patient groups -- Interactions with other drugs.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Aspirin.
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Dewey Decimal Classification
Koha item type Books
Holdings
Lost status Source of classification or shelving scheme Damaged status Not for loan Home library Current library Shelving location Date acquired Source of acquisition Inventory number Total Checkouts Full call number Barcode Date last seen Price effective from Koha item type
  Dewey Decimal Classification     Main library Main library A11 01/01/2009 Academic bookshop DO   615.3137 B.A.C 00007291 19/02/2025 13/09/2010 Books